Tscan Therapeutics
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
830 Winter St, Waltham, Massachusetts, 0...Phone Number
(857) 399-9500Website
www.tscan.comRevenue
$7.1 MillionStock Symbol
TCRXIndustry
About Tscan Therapeutics
TScan Therapeutics is a clinical-stage biotechnology company headquartered in Waltham, Massachusetts. Founded in 2018, the company develops T cell receptor-engineered T cell (TCR-T) therapies for treating patients with cancer, including hematologic malignancies and solid tumors. Using its proprietary discovery platform, TScan identifies how T cells naturally recognize and fight cancer, and also researches T cell involvement in autoimmune disorders. The company is publicly traded on Nasdaq.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: TCRXShow moreTscan Therapeutics Org Chart
Compare Similar Companies to Tscan Therapeutics
Compare insights from companies similar to Tscan Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Tscan Therapeutics Tech Stack
A closer look at the technologies used by Tscan Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tscan Therapeutics
Sign Up For FreeTo access detailed company insights
TScan Therapeutics is a clinical-stage biotechnology company headquartered in Waltham, Massachusetts. Founded in 2018, the company develops T cell receptor-engineered T cell (TCR-T) therapies for treating patients with cancer, including hematologic malignancies and solid tumors. Using its proprietary discovery platform, TScan identifies how T cells... Read More